Medicare AdvantageCoverageMedium impact
MA05.027e, Implantable Cardioverter Defibrillators
Independence Blue Cross·Cardiology, Cardiothoracic Surgery, Internal Medicine·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA05.027e for Implantable Cardioverter Defibrillators has been reissued effective April 1, 2026. This is a policy update that may affect coverage criteria, prior authorization requirements, or documentation standards for ICD procedures under Medicare Advantage plans.
Action Required
By April 1, 2026: Billing team must review the complete MA05.027e policy document at the source URL to identify specific changes to ICD coverage criteria, prior authorization requirements, or documentation standards. Update billing workflows and staff training accordingly based on the detailed policy content.